Rapid Microbiology Testing Market to Reach $9.72B by 2032

Growth driven by PCR, NGS adoption and rising demand for faster infection diagnosis

Published on Feb. 6, 2026

Got story updates? Submit your updates here. ›

The global rapid microbiology testing market is expected to reach a valuation of $9.72 billion by 2032, growing at a CAGR of 9.24% from 2024 to 2032. The market is driven by the need for faster infection diagnosis and pharmaceutical quality control, as well as technological advancements in instruments, reagents, and automated systems.

Why it matters

Rapid microbiology testing is crucial for early detection of infectious diseases, enabling timely treatment interventions and reducing disease transmission. This is especially important in the US, where over 20 million infectious disease cases are reported annually. Faster and more accurate diagnostics can improve patient outcomes and community health resilience.

The details

The market is shifting from traditional culture-based testing to real-time monitoring methods like PCR and NGS, which can deliver results much faster than the 24-48 hours required for culture-based tests. Growth-based rapid microbiology testing, which accounts for over 37% of the market, is particularly dominant in industries like pharmaceuticals, food and beverage, and healthcare where rapid contamination detection is critical.

  • The rapid microbiology testing market is expected to grow from $4.39 billion in 2023 to $9.72 billion by 2032.
  • In 2023, the pharmaceutical industry saw a 20% increase in the uptake of growth-based rapid microbiology testing.

The players

Astute Analytica

A global market research and advisory firm that provided the data and analysis on the rapid microbiology testing market.

North America

The largest regional market for rapid microbiology testing, commanding over 38.2% of the global total in 2023.

Got photos? Submit your photos here. ›

The takeaway

The rapid growth of the microbiology testing market underscores the critical importance of fast, accurate diagnostics in controlling infectious disease outbreaks and improving patient care. As real-time monitoring technologies like PCR and NGS become more prevalent, healthcare providers will be better equipped to identify and respond to microbial threats, enhancing community health resilience.